Suppr超能文献

经鼻内镜经斜坡入路切除斜坡及后颅窝前部肿瘤(140例手术治疗结果)

Endoscopic endonasal transclival removal of tumors of the clivus and anterior region of the posterior cranial fossa (results of surgical treatment of 140 patients).

作者信息

Shkarubo Alexey N, Koval Konstantin V, Chernov Ilia V, Andreev Dmitry N, Kurnosov Alexey B, Panteleyev Andrey A

机构信息

Federal State Autonomous Institution, N.N. Burdenko National Medical Research Center of Neurosurgery of the Ministry of Health of the Russian Federation (N.N. Burdenko NMRCN), 4-ya Tverskaya-YAmskaya street, 16, Moscow, Russian Federation.

出版信息

Chin Neurosurg J. 2018 Nov 15;4:36. doi: 10.1186/s41016-018-0144-5. eCollection 2018.

Abstract

BACKGROUND

Until recently, tumors of the clivus and the anterior region of the posterior cranial fossa were considered extremely difficult to access and often inoperable using standard transcranial approaches. With the introduction into the neurosurgical practice of minimally invasive methods utilizing endoscopic techniques, it became possible to effectively remove hard-to-reach tumors, including central tumors of the anterior region of the posterior cranial fossa.

METHODS

From 2008 to the present time, the inpatient institution has operated on 140 patients with various tumors of the base of the skull, localized to the clivus and anterior region of the posterior cranial fossa (65 men and 75 women). The age of patients ranged from 3 to 74 years. Tumor distribution according to the histopathological features was as follows: chordomas, 103 (73.57%); meningiomas, 12 (8.57%); pituitary adenomas, 9 (6.43%); fibrous dysplasia, 4 (2.86%); cholesteatoma, 3 (2.14%); craniopharyngiomas, 2 (1.43%); plasmacytomas, 2 (1.43%); and other tumors (giant cell tumor, neurohypophyseal glioma, osteoma, carcinoid, chondroma), 5 (3.57%). The tumors had the following size distribution: giant (more than 60 mm), 35 (25%); large (35-59 mm), 83 (59.3%); medium (21-35 mm), 21 (15%); and small (less than 20 mm), 1 (0.7%). In 11 cases, intraoperative monitoring of the cranial nerves was performed (21 cranial nerves were identified).

RESULTS

Upper, middle, and lower transclival approaches provide access to the anterior surface of the upper, middle, and lower neurovascular complexes of the posterior cranial fossa. The chordoma cases were distributed as follows according to extent of removal: total removal, 68 (66.02%); subtotal removal, 25 (24.27%); and partial removal, 10 (9.71%). The adenomas of the pituitary gland were removed totally in 6 cases, subtotally in 1 case and partially in 2 cases. The meningiomas were removed totally in 1 case, subtotally in 5 cases, and partially in 5 cases, with less than 50% of the tumor removed in 1 case. Other tumors (cholesteatoma, craniopharyngioma, fibrous dysplasia, giant cell tumor, glioma of the neurohypophysis, osteoma, plasmacytoma, carcinoid, and chondroma) were removed totally in 9 cases and subtotally in 7 cases. Postoperative CSF leaks occurred in 9 cases (6.43%) and meningitis in 13 cases (9.29%). Oculomotor disorders developed in 19 patients (13.57%), 12 of which regressed during the period from 4 to 38 days after surgery, and 7 of which were permanent. In 2 cases, surgical treatment had a lethal outcome (1.43%).

CONCLUSION

The endoscopic endonasal transclival approach can be used to obtain access to the centrally located tumors of the posterior cranial fossa. It is an alternative to transcranial approaches in the surgical treatment of tumors of the clivus. The results of using this approach are comparable with the results of transcranial and transfacial approaches and, in some cases, surpass them in effectiveness. The extended endoscopic endonasal posterior (transclival) approach, considering its minimally invasive nature, allows fora radical and low-risk (in terms of postoperative complications and lethality) removal of various skull base tumors of central localization with the involvement and without the involvement of the clivus, which, until recently, were considered to be almost inoperable.

摘要

背景

直到最近,斜坡和后颅窝前部区域的肿瘤仍被认为极难通过标准经颅入路到达,且通常无法手术切除。随着利用内镜技术的微创方法引入神经外科实践,有效切除难以触及的肿瘤成为可能,包括后颅窝前部区域的中央肿瘤。

方法

从2008年至今,该住院机构对140例患有各种颅底肿瘤的患者进行了手术,这些肿瘤位于斜坡和后颅窝前部区域(男性65例,女性75例)。患者年龄范围为3至74岁。根据组织病理学特征,肿瘤分布如下:脊索瘤103例(73.57%);脑膜瘤12例(8.57%);垂体腺瘤9例(6.43%);骨纤维异常增殖症4例(2.86%);胆脂瘤3例(2.14%);颅咽管瘤2例(1.43%);浆细胞瘤2例(1.43%);以及其他肿瘤(巨细胞瘤、神经垂体胶质瘤、骨瘤、类癌、软骨瘤)5例(3.57%)。肿瘤大小分布如下:巨大型(超过60mm)35例(25%);大型(35 - 59mm)83例(59.3%);中型(21 - 35mm)21例(15%);小型(小于20mm)1例(0.7%)。11例患者术中进行了颅神经监测(共识别出21条颅神经)。

结果

经斜坡上、中、下入路可到达后颅窝上、中、下神经血管复合体的前表面。脊索瘤病例根据切除范围分布如下:全切68例(66.02%);次全切25例(24.27%);部分切除10例(9.71%)。垂体腺瘤6例全切,1例次全切,2例部分切除。脑膜瘤1例全切,5例次全切,5例部分切除,其中1例切除肿瘤不到50%。其他肿瘤(胆脂瘤、颅咽管瘤、骨纤维异常增殖症、巨细胞瘤、神经垂体胶质瘤、骨瘤、浆细胞瘤、类癌、软骨瘤)9例全切,7例次全切。术后脑脊液漏9例(6.43%),脑膜炎13例(9.29%)。19例患者出现动眼神经功能障碍(13.57%),其中12例在术后4至38天内恢复,7例为永久性障碍。2例手术治疗导致死亡(1.43%)。

结论

内镜经鼻经斜坡入路可用于到达后颅窝中央部位的肿瘤。它是斜坡肿瘤手术治疗中经颅入路的替代方法。使用该入路的结果与经颅和面入路的结果相当,在某些情况下,其有效性超过它们。扩展内镜经鼻后(经斜坡)入路,考虑到其微创性质,允许对各种中央定位的颅底肿瘤进行根治性且低风险(就术后并发症和死亡率而言)的切除,无论是否累及斜坡,而这些肿瘤直到最近还被认为几乎无法手术切除。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验